19 HARTUM STREET, BYNET BUILDING, 3RD FL, Jerusalem, L3
Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Reports Second Quarter 2026 Financial Results and Operational Highlights
Leading the Next Phase of Interventional Psychiatry Technology. Evidence. Scale. Growth.
Announces Strategic Investment in Radial Health, Inc.
Announces Minority-Stake Investment in Behavioral
Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Notice of Exempt Offering of Securities
No filings found
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
S-8 POS
Correspondence
Submission Upload